Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study.

MLA

Curigliano, Giuseppe, et al. “Alpelisib in Combination with Everolimus ± Exemestane in Solid Tumours: Phase Ib Randomised, Open-Label, Multicentre Study.” European Journal of Cancer (Oxford, England : 1990), vol. 151, July 2021, pp. 49–62. EBSCOhost, https://doi.org/10.1016/j.ejca.2021.03.042.

APA

Curigliano, G., Martin, M., Jhaveri, K., Beck, J. T., Tortora, G., Fazio, N., Maur, M., Hubner, R. A., Lahner, H., Donnet, V., Ajipa, O., Li, Z., Blumenstein, L., & Andre, F. (2021). Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. European Journal of Cancer (Oxford, England : 1990), 151, 49–62. https://doi.org/10.1016/j.ejca.2021.03.042

Chicago

Curigliano, Giuseppe, Miguel Martin, Komal Jhaveri, J T Beck, Giampaolo Tortora, Nicola Fazio, Michela Maur, et al. 2021. “Alpelisib in Combination with Everolimus ± Exemestane in Solid Tumours: Phase Ib Randomised, Open-Label, Multicentre Study.” European Journal of Cancer (Oxford, England : 1990) 151 (July): 49–62. doi:10.1016/j.ejca.2021.03.042.